TRANSFORM-HF Ancillary Mechanistic Study
Launched by INOVA HEALTH CARE SERVICES · Jan 7, 2021
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Patients who are enrolling in the TRANSFORM-HF study or being prescribed Torsemide or Furosemide at hospital discharge will provide blood and urine at the time of study enrollment (within 72 hours of hospital discharge) and at 90 days (+/- one week) after hospital discharge.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participation in the TRANSFORM-HF trial or prescription of Torsemide or Furosemide
- • Willing to provide blood and urine sample at enrollment and follow-up
- Exclusion Criteria:
- • Inability or unwillingness to comply with the study requirements
About Inova Health Care Services
Inova Health Care Services is a leading healthcare organization dedicated to providing high-quality, patient-centered care across a comprehensive range of medical specialties. With a commitment to advancing clinical research and innovation, Inova actively sponsors and conducts clinical trials aimed at improving health outcomes and enhancing treatment options for patients. The organization combines state-of-the-art facilities, a skilled team of medical professionals, and a robust research infrastructure to facilitate groundbreaking studies that address pressing health challenges. Through its dedication to excellence in clinical research, Inova Health Care Services strives to contribute to the evolving landscape of healthcare and improve the lives of individuals in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
New Orleans, Louisiana, United States
New Haven, Connecticut, United States
Chapel Hill, North Carolina, United States
Durham, North Carolina, United States
Manhasset, New York, United States
Falls Church, Virginia, United States
Norfolk, Virginia, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Lauren Cooper, MD, MHS
Principal Investigator
Northwell Health
Christopher deFilippi, MD
Principal Investigator
Inova Health Care Services
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials